orantinib has been researched along with Experimental Hepatoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Hiramatsu, Y; Kamiya, K; Kawabata, T; Kikuchi, H; Kitagawa, M; Kondo, K; Konno, H; Ohta, M; Tanaka, T; Yamamoto, M | 1 |
| Choi, SH; Chung, JW; Im, SA; Jae, HJ; Jun, S; Kim, HC; Park, JH; Yamasaki, Y | 1 |
| Bucana, CD; Davis, DW; Drazan, KE; Ellis, LM; Liu, W; McConkey, DJ; McMahon, G; Ogura, Y; Reinmuth, N; Shaheen, RM; Tseng, WW; Vellagas, R; Wieczorek, AA | 1 |
3 other study(ies) available for orantinib and Experimental Hepatoma
| Article | Year |
|---|---|
TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche.
Topics: Animals; Cell Movement; Chemokine CXCL1; Colonic Neoplasms; Gene Expression Profiling; Humans; Indoles; Interleukin-12 Subunit p40; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Neutrophils; Oligonucleotide Array Sequence Analysis; Oxindoles; Propionates; Pyrroles; Receptors, Interleukin-8B; RNA, Messenger; Xenograft Model Antitumor Assays | 2008 |
Augmentation of chemotherapeutic infusion effect by TSU-68, an oral targeted antiangiogenic agent, in a rabbit VX2 liver tumor model.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Ethiodized Oil; Indoles; Infusions, Intravenous; Liver Neoplasms, Experimental; Neovascularization, Pathologic; Oxindoles; Propionates; Pyrroles; Rabbits; Statistics, Nonparametric; Tomography, X-Ray Computed | 2012 |
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Division; Cell Survival; Colonic Neoplasms; Endothelium, Vascular; Indoles; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oxindoles; Propionates; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Fibroblast Growth Factor; Receptors, Growth Factor; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor | 2001 |